This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026
We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1
What this version reported
ClinicalTrials.gov lists a Novo Nordisk pediatric study as recruiting, updated July 17, 2026.↗
Organizations named in cited records:
- Novo Nordisk A/S↗
Trial records: NCT07253285
Sources for this version
- 1Cagrilintide and CagriSema in Children and Adolescents With Excess Body Weight · record history version 5 · last update posted 2026-07-17 ↗
ClinicalTrials.gov · Official source · Source checked July 22, 2026